These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1800137)

  • 1. [The adequacy of a new method for assessing the vestibular protective effect of biologically active substances].
    Karkishchenko NN; Dimitriadi NA
    Farmakol Toksikol; 1991; 54(5):14-6. PubMed ID: 1800137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
    Collins WE; Schroeder DJ; Elam GW
    Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ephedrine on the blood supply and oxygen regimen of the brain during motion sickness].
    Skoromnyĭ NA
    Farmakol Toksikol; 1987; 50(2):93-7. PubMed ID: 3582644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA
    Kosm Biol Aviakosm Med; 1977; 11(6):50-3. PubMed ID: 22775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dependence of vestibular reactions on the frequency of the action of reciprocating accelerations].
    Lapaev EV; Vorob'ev OA; Ivanov VV
    Zh Ushn Nos Gorl Bolezn; 1979; (5):33-7. PubMed ID: 315137
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological interventions for motion sickness: cardiovascular effects.
    Sunahara FA; Farewell J; Mintz L; Johnson WH
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
    Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of vestibuloprotectors on the cyclic nucleotide system in experimental motion sickness].
    Leshchiniuk II; Konovalova EO; Kvitchataia AI; Shamraĭ VG; Bobkov IuG
    Patol Fiziol Eksp Ter; 1989; (1):26-8. PubMed ID: 2785671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug effectiveness on experimental optokinetic and vestibular motion sickness.
    Brandt T; Dichgans J; Wagner W
    Aerosp Med; 1974 Nov; 45(11):1291-7. PubMed ID: 4611183
    [No Abstract]   [Full Text] [Related]  

  • 10. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of the loop diuretic furosemide on short latency auditory and vestibular-evoked potentials.
    Freeman S; Plotnik M; Elidan J; Sohmer H
    Am J Otol; 1999 Jan; 20(1):41-5. PubMed ID: 9918170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vestibulo-protective properties of regulatory peptides].
    Drozd IuV; Iasnetsov VV; Shashkov VS
    Biull Eksp Biol Med; 1988 Jul; 106(7):50-2. PubMed ID: 2456793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the influence of anxiolytics on the pain reactions of rats compared to the effect of morphine].
    Korneev AIa; Vasilenko GF; Bragin EO
    Biull Eksp Biol Med; 1987 May; 103(5):590-2. PubMed ID: 2885045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental validation of pharmacological agents to arrest the vestibulo-autonomic syndrome (motion sickness)].
    Shashkov VS; Kotovskaia AR; Orlov OI; Koloteva MI; Shashkov AV; Karsanova SK
    Eksp Klin Farmakol; 1999; 62(6):11-5. PubMed ID: 10650518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new natural model of elevated anxiety in rats].
    Rodina VI; Krupina NA; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1993 Aug; 116(8):127-30. PubMed ID: 8274676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tranquilizers on animal resistance to adequate stimulus exposure of the vestibular apparatus].
    Maksimovich IaB; Khinchikashvili NV
    Farmakol Toksikol; 1979; 42(6):606-10. PubMed ID: 40818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the drug Humex on the development of experimental motion sickness].
    Bodo G; Elkan K; Bentse G
    Kosm Biol Aviakosm Med; 1989; 23(3):84. PubMed ID: 2503657
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vestibular tests in studying the spectrum of action of psychotropic preparations].
    Voinova II; Lavretskaia EF; Privol'neva TP
    Farmakol Toksikol; 1975; 38(6):658-9. PubMed ID: 1084286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human assay of antimotion sickness drugs.
    Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
    Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the antimotion sickness effects of psychostimulants.
    Kohl RL; Lewis MR
    Aviat Space Environ Med; 1987 Dec; 58(12):1215-8. PubMed ID: 3322253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.